ABSTRACT. Cytochrome P450 (CYP) 1B1 is involved in the metabolic activation of various procarcinogens, and some CYP1B1 genetic variants alter CYP1B1-dependent procarcinogen metabolism. Cynomolgus and rhesus macaques are frequently used in toxicity tests due to their evolutionary closeness to humans. In this study, we attempted to identify CYP1B1 genetic variants in 13 cynomolgus and 4 rhesus macaques. A total of 17 genetic variants were identified, including 8 non-synonymous genetic variants, indicating that, similar to humans, CYP1B1 is polymorphic in macaques. These CYP1B1 genetic variants could be the basis for understanding potential interanimal differences in macaque CYP1B1-dependent metabolism of promutagens.
Cytochrome P450 (CYP) 1B1 belongs to the CYP1 family, which also consists of CYP1A1 and CYP1A2 in human. CYP1B1, and CYP1A1, play a major role in the activation of most carcinogenic polycyclic aromatic hydrocarbons [7] . Human CYP1B1 is expressed in the extrahepatic tissues, including kidney, thymus, spleen, lung, colon, intestine, uterus, mammary gland, ovary, and prostate [10] . Genetic variants have been identified in human CYP1B1, some of which are important for CYP1B1 function [11] . For example, a previous study showed that L432V increased the catalytic activity of human CYP1B1 [1, 6] , probably due to alterations in the tertiary or quaternary structure of the CYP1B1 protein [11] , and that N453S is associated with a decrease in protein expression due to increased degradation of CYP1B1 protein [2] . The CYP1B1*3 haplotype is associated with an elevated expression of CYP1B1 mRNA in lymphocytes that are treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin [5] . Moreover, several CYP1B1 genotypes have been associated with an increased risk of cancer: L432V with breast, endometrial, ovarian, and prostate cancer; A119S with endometrial and prostate cancer; N453S with endometrial cancer [11] .
Macaques, including cynomolgus macaque (Macaca fascicularis) and rhesus macaque (Macaca mulatta), are frequently used in biomedical research, including toxicology and neuroscience, due to their evolutionary closeness to humans. In macaques, metabolic activation of carcinogen such as 2-amino-3-methylimidazo[4,5-f]quinoline, which is partly mediated by CYP1B1 in human, results in DNA adduct formation and carcinogenesis in liver and development of hepatocelluler carcinoma [9] . Numerous CYPs have been identified in cynomolgus macaque and rhesus macaque, and are highly identical (generally >99%) in amino acids between the two lineages [14] . Expression of macaque CYP1B1 mRNA has been detected in brain regions, including frontal cortex, hippocampus, thalamus, and amygdala [8] . Since macaques have a diverse genetic background, similar to human, as evidenced by identification of genetic variants in a number of genes, including CYPs [15, 16] , macaques might possess numerous CYP1B1 genetic variants. Some variants could account for inter-animal differences in CYP1B1-dependent metabolism of promutagens, making it difficult to interpret the data obtained. To determine if macaque CYP1B1 is polymorphic, genomes of 13 cynomolgus and 4 rhesus macaques were screened for genetic variants in this study.
To identify CYP1B1 genetic variants, whole blood samples were collected from purpose-bred animals, including 13 cynomolgus macaques (6 from Indochina and 7 from Indonesia, 4-5 years of age, weighing 3-5 kg) and 4 rhesus macaques (from China, 7 years of age, weighing 3-5 kg). Genomic DNA was extracted from these blood samples using the PUREGENE DNA isolation kit (Gentra Systems, Minneapolis, MN) according to the manufacturer's instructions. This study was reviewed and approved by the Institutional Animal Care and Use Committee of Shin Nippon Biomedical Laboratories, Ltd (Kainan, Japan). Each genome sample was used as a template for polymerase chain reaction (PCR) that was carried out as described previously [15] . Briefly, PCR was performed in a 20-l reaction containing 1 ng of genomic DNA, 5 pmole of each primer, and 1 unit of EX Taq HS DNA polymerase (Takara, Tokyo, Japan), using a thermal cycler (Applied Biosystems, Foster City, CA). Thermal cycling was performed with an initial denaturation at 94C for 1 min, followed by 35 cycles of 10 sec at 98C, 30 sec at 55C, and 90 sec at 72C; and a final extension step of 5 min at 72C. PCR products were sequenced using an ABI PRISM BigDye Terminator v3.0 Ready Reaction Cycle Sequencing Kit (Applied Biosystems), followed by electrophoresis on an ABI PRISM 3730 DNA Analyzer (Applied Biosystems). The primers used for PCR and sequencing are listed in Table 1 . Sequence data were analyzed using Sequencher (Gene Codes, Ann Arbor, MI).
A comparison of obtained sequences with the putative C Y P 1 B 1 c o d i n g s e q u e n c e o f r h e s u s m a c a q u e (XM_001109361) identified a total of 18 genetic variants, including 14 in exon 2 and 4 in exon 3 ( Table 2 ). Non-coding exon 1 was excluded from the analysis, because the aim of this study was to examine mutations that could potentially affect protein function, such as non-synonymous genetic variants, and nucleotide insertions or deletions in the coding region. Among the 18 genetic variants identified, 8 (44.4%) were non-synonymous genetic variants, including c.698G>T in substrate recognition site (SRS) 2. SRSs are important for protein function, thus this genetic variant could influence protein function. In human, non-synonymous genetic variants alter the metabolic activity of CYP1B1. For example, L432V has been shown to be associated with increased catalytic activity of human CYP1B1 [1, 6] . It is of great interest to investigate the effect of the non-synonymous genetic variants identified in this study on CYP1B1 protein function.
A comparison of allele frequency between cynomolgus and rhesus macaques revealed that 1 (5.6%) out of a total 18 non-synonymous genetic variants was shared by both macaque lineages. A previous study also found many genetic variants in a large number of genes were shared between the two lineages [13] , including CYP3A4 and CYP3A5 [15] . On the other hand, 12 and 5 genetic variants were unique to cynomolgus and rhesus macaques, respectively (Table 2) . Among the 12 genetic variants found only in cynomolgus macaques, 4 and 3 genetic variants appeared to be unique to Indochinese and Indonesian cynomolgus macaques, respectively. A non-synonymous genetic variant c.698G>T (in SRS2) was found only in Indonesian cynomolgus macaques. This genetic variant, if it has a substantial influence on CYP1B1 protein function, could account for the difference in CYP1B1-dependent metabolic activity between cynomolgus and rhesus macaques or between Indochinese and Indonesian cynomolgus macaques. An uneven distribution of the alleles was also found in Chinese and Indian rhesus macaques [3, 4] , and such genetic heterogeneity could account for variability in protein function between different populations.
By genetic linkage analysis and mutation studies, human CYP1B1 has been associated with several glaucoma phenotypes, as a causative gene in primary congenital glaucoma, as a modifier gene and, on rare occasions, as a causative gene, in primary open-angle glaucoma [17] . In human, CYP1B1 expression is detected in iris and the ciliary body at relatively high levels, and in cornea, retinal-pigment epithe- lium, and retina at relatively low levels [12] . Thus, CYP1B1 is expected to play an important role in development of glaucoma phenotype. Considering the molecular resemblance of CYPs in macaque and human [14] , mutations corresponding to those associated with human glaucoma, if identified, might be useful in establishing an animal model for the investigation of glaucoma in macaques. In this study, however, none of the genetic variants identified corresponded to human CYP1B1 variants associated with glaucoma, coinciding well with the apparently normal animals analyzed. Since only 17 animals were analyzed in this study, more genetic variants might be identified with an increased number of genome samples. An inclusion of the animals suffering from glaucoma in the analysis, if possible, would increase the chance to identify the genetic variants corresponding to human CYP1B1 variants associated with glaucoma.
In conclusion, our initial screening has successfully identified a total of 18 CYP1B1 genetic variants, including 8 non-synonymous genetic variants in cynomolgus and rhesus macaques. None of these genetic variants corresponded to those associated with glaucoma in human. One of the nonsynonymous genetic variants identified was in SRS2, a protein domain potentially important for protein function. Many of the genetic variants were unique to cynomolgus or rhesus macaques, and to Indochinese or Indonesian cynomolgus macaques. In this study, macaque CYP1B1 was found to be polymorphic, and the data presented are useful for future investigations of the potential inter-animal differences of CYP1B1-dependent metabolic properties in macaques.
